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INTRODUCTION
New postoperative atrial fibrillation (POAF) is one of the 
most critical and common complications after cardiovascular 
surgery, precipitating early and late morbidities such as cardio-
vascular events, thromboembolism, cerebrovascular events, 
prolonged hospital stay and readmissions to the intensive care 
unit (ICU) and hospital, organ failure, as well as increased 
health care costs and mortality [1–3]. Atrial fibrillation (AF) is 
a hazardous and widespread complication following coronary 
artery bypass graft (CABG), with an incidence of 20% to 50%, 
and with incidence peaks occurring two to three days after 
surgery [1–3]. The pathophysiological mechanism of AF is 
highly complex and is affected by diverse factors, and a vari-
ety of diagnostic modalities have been shown to be useful in 
predicting or diagnosis of POAF [4, 5]. 
Conventionally, diagnosis and management of AF have 
been focused on the patient’s medical history, examination, 
and detection of AF through cardiac monitoring [6, 7]. Com-
plete blood count (CBC) is an imperative blood test in clinical 
practice routinely used in the examination of cardiovascular 
diseases [8, 9]. The association of CBC test with the occur-
rence and recurrence of paroxysmal, persistent, and perma-
nent AF in patients not undergoing cardiac surgery has been 
well reported and documented [8]. However, the diagnostic 
performance of haematological indices for AF after cardiac 
surgery has remained unexplored.
Various studies have been recently published focusing 
on the association of haematological indices with the occur-
rence of POAF. However, so far the data from the studies have 
been largely inconclusive. This comprehensive meta-analysis 
sought to determine the strength of evidence for evaluating 
the association of platelet count, mean platelet volume (MPV), 
platelet distribution width (PDW), white blood cell (WBC)
count, neutrophil-to-lymphocyte ratio (NLR), red blood cell 
(RBC) count, red blood cell distribution width (RDW), mean 
corpuscular volume (MCV), mean corpuscular haemoglobin 
concentration (MCHC), haematocrit (HCT), and haemoglobin 
(Hb) with the occurrence of POAF.
METHODS
Literature search
A comprehensive literature search was carried out by three 
investigators independently in medical databases (Med-
line/PubMed, Web of Science, Embase, Ovid, Science 
Direct, and Google Scholar) from their inception until 5th 
May 2017 in order to identify relevant studies on the as-
sociation of primary haematological indices such as platelet 
count, MPV, PDW, WBC count, NLR, RBC count, RDW or 
secondary haematological indices including MCV, HCT, and 
Hb, with the occurrence of POAF. Predefined keywords for 
searching were as follows: “platelet count”, “mean platelet 
volume”, “MPV”, “platelet distribution width” “PDW”, 
“white blood cell count”, “leucocyte”, “WBC”, “neutrophil 
to lymphocyte ratio”, “NLR”, “red blood cell count”, “RBC 
count”, “red blood cell distribution width”, “RDW”, and 
“atrial fibrillation” or “supraventricular arrhythmia” and 
“cardiac surgery”, “coronary artery bypass surgery”, “CABG”, 
“valvular surgery”, “surgery”. The sample sizes of the stud-
ies, time and language of publications were not restricted. 
Abstracts without peer-review or those only published as 
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congress presentations, as well as grey literature, were not 
included in the study. Studies were excluded also if they had 
the report of non-matched data as mean ± standard devia-
tion (SD) or median [minimum–maximum] or they had not 
reported demographic details in AF and SR group separately. 
All retrieved references of the enrolled studies, recently 
published review articles, and meta-analyses were checked 
to find additional studies not indexed in common databases.
Study selection
Inclusion criteria to be enrolled in the analysis were as fol-
lows: 1) human subjects; 2) case-control or cohort studies; 
3) patients undergoing either CABG or heart valve surgery, 
or a combination of both; and 4) studies comparing patients 
with POAF and postoperative sinus rhythm (POSR) in terms 
of haematological indices.  
Data extraction and outcome measures 
Five investigators (S.A-H-S, A.S, S.Y, M-P.S, and S.J.M) inde-
pendently searched and extracted the data. To resolve the 
discrepancies a consensus standardised abstraction checklist 
was used for recording data in each included study. Subgroup 
analyses of disparities in the patients’ characteristics were 
performed for exploration of heterogeneity among the stud-
ies examining the following items: (1) the time of publication 
(before 2000 vs. after 2000); (2) geographical zone (Africa, 
Asia, Europe, North-America, Oceania, South-America); 
(3) study design (case-control vs. cohort); (4) sample size 
(≤ 200 vs. > 200); (5) mean age (≤ 60 vs. > 60 years); 
(6) percentage of men (≤ 70% vs. > 70%); (7) history of dia-
betes (≤ 30% vs. > 30%); (8) history of hypertension (≤ 70% 
vs. > 70%); (9) cigarette smoking (≤ 30% vs. > 30%); 
(10) history of myocardial infarction (≤ 20% vs. > 20%); 
(11) preoperative left ventricular ejection fraction (≤ 50% 
vs. > 50%); (12) preoperative use of drugs such as beta-block-
ers, statins, diuretics, angiotensin converting enzyme inhibitors, 
or angiotensin receptor blockers (for each: ≤ 70% vs. > 70%); 
(13) type of surgery (isolated CABG, isolated valvular surgery, 
combined procedures); (14) method of surgery (on-pump, 
off-pump); (15) status of surgery (elective, non-elective), (16) 
cross-clamp time (≤ 60 min vs. > 60 min); and (17) cardio-
pulmonary bypass time (≤ 100 min vs. > 100 min).
Homogenisation of extracted data 
Continuous data were presented as mean ± SD. When 
interquartile ranges were reported, the mean was calculated 
as (minimum+maximum+2[median])/4 and SD as (maxi-
mum–minimum)/4 for groups with sample sizes of n ≤ 70, 
and (maximum–minimum)/6 for n > 70 [10].
Quality assessment and statistical analysis 
Three investigators (T.L, L.M, and M.G) independently evalu-
ated the Newcastle-Ottawa Scale and design of the studies 
to assess the quality of the studies [11]. Total scores ranged 
between 0 (worst) and 9 (best quality) for case-control or 
cohort studies. For non-categorical data, pooled effect size 
was expressed as weighted mean difference (WMD) with 
95% confidence interval (CI). Significant heterogeneity was 
observed among the studies considering p value < 0.1 for 
Q test or I2 > 50%. Heterogeneity among the trials was 
tested by applying a random effect model when indicated. 
Publication biases were evaluated using the Begg’s test, which 
examines the presence of association among the effect esti-
mates and their variances. Statistical significance level was 
considered as p value < 0.05. Data analysis was conducted 
by STATA (version 11.0, Stata Corporation, College Station, 
Texas) using METAN and METABIAS commands.
RESULTS
Literature search strategy and included studies 
A total of 732 studies were extracted from the literature 
search and screened databases, of which 710 (96.9%) were 
excluded after detailed evaluation through the first review for 
either unnecessary information (n = 384), insufficient report 
of endpoints of interest (n = 312), or report of non-matched 
data as mean ± SD or median [minimum–maximum] (n = 14). 
Finally, 22 studies were analysed through meta-analysis [12– 
–33]; including a total of 6098 patients (details about excluded 
and included studies were presented in Supplemental Table 1 
— see journal website).
Association of preoperative haematological 
indices with the occurrence of POAF 
Platelet count 
A total of 1417 cases were selected from seven studies, of 
which 392 were assigned to the POAF and 1025 to the POSR 
(Table 1). The population of the studies ranged from 94 to 
662 patients, 79.34% males (mean age: 64.23 years) (Table 1). 
Mean platelet count was 235.53 × 109/L in the POAF group 
and 241.67 × 109/L in the POSR group (Table 2). Pooled 
analysis indicated that the mean platelet count was statistically 
lower in patients with POAF (negative predictor) than POSR 
cases with WMD of –7.07 × 109/L (95% CI –11.75 to –2.39; 
p < 0.001) by utilising a random effect model (Fig. 1). There 
was a significant heterogeneity among the studies (I2 = 57.1%; 
heterogeneity p = 0.03), indicating a random effect. 
MPV 
A total of 1744 patients were enrolled from six studies, of 
whom 476 were allocated to the POAF group and 1268 to 
the POSR group (Table 1). The populations of the studies 
ranged from 94 to 1138 patients, 73.82% males (mean age, 
63.5 years) (Table 1). Mean level of MPV was 9.35 FL in 
the POAF and 9.05 FL in the POSR group (Table 2). Pooled 
analysis showed that MPV was significantly greater in patients 
with POAF (positive predictor) compared to POSR with WMD 
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Table 2. Information about haematological indices and these levels in each study
First author Markers Levels
Measurement of hematologic indices 
Jacob [12] WBC, NLR Preoperative:
WBC [AF: 7.8 ± 2.6 vs. SR: 7.7 ± 1.9]
NLR [AF: 2.72 ± 0.26 vs. SR: 2.48 ± 0.27]
Saskin [13] PC, WBC, HCT, Hb Preoperative:
PC [AF: 264 ± 42.3 vs. SR: 279 ± 49.6]
WBC [AF: 7.75 ± 0.93 vs. SR: 7.52 ± 1.05]
HCT [AF: 40.9 ± 3.43 vs. SR: 41.1 ± 3.40]
Hb [AF: 13.3 ± 0.93 vs. SR: 13.85 ± 1.16]
Saskin [14] MPV, HCT, Hb Preoperative:
MPV [AF: 9.03 ± 0.74 vs. SR: 8.32 ± 0.6]
HCT [AF: 40.7 ± 4 vs. SR: 40.6 ± 4.1]
Hb [AF: 13.3 ± 1.4 vs. SR: 13.4 ± 1.5]
Postoperative:
MPV [AF: 9.9 ± 0.9 vs. SR: 8.8 ± 0.6]
HCT [AF: 28.7 ± 3.2 vs. SR: 29.1 ± 3.1]
Hb [AF: 9.1 ± 1.2 vs. SR: 9.2 ± 1.1]
Cerit [15] PC, MPV, WBC, NLR, Hb Preoperative:
PC [AF: 214.9 ± 61.1 vs. SR: 238.2 ± 64.1]
MPV [AF: 10.5 ± 1.1 vs. SR: 10.3 ± 0.9]
WBC [AF: 7.7 ± 2.4 vs. SR: 7.5 ± 1.8]
NLR [AF: 2.9 ± 2 vs. SR: 2.1 ± 0.8]
Hb [AF: 13.4 ± 1.9 vs. SR: 13.7 ± 1.6]
Anatolevna [16] WBC Preoperative:
WBC [AF: 6.7 ± 2 vs. SR: 7 ± 1.8]
Postoperative:
WBC [AF: 13.5 ± 3.4 vs. SR: 13.4 ± 3.3]
Gecmen [17] PC, MPV, WBC, RDW, Hb Preoperative:
PC [AF: 253 ± 68 vs. SR: 231 ± 57]
MPV [AF: 7.5 ± 0.9 vs. SR: 7.4 ± 0.9]
WBC [AF: 8.1 ± 2.2 vs. SR: 8.3 ± 2.2]
RDW [AF: 15 ± 1.4 vs. SR: 15 ± 1.2]
Hb [AF: 13.1 ± 1.5 vs. SR: 13.5 ± 1.5]
Korantzopoulos [18] PC, MPV, WBC, RDW, Hb Preoperative:
PC [AF: 212.52 ± 18.87 vs. SR: 213.2 ± 17.2]
MPV [AF: 10.97 ± 0.47 vs. SR: 10.90 ± 0.4]
WBC [AF: 8.18 ± 1 vs. SR: 7.88 ± 0.85]
RDW [AF: 14.25 ± 0.5 vs. SR: 13.3 ± 0.4]
Hb [AF: 13.27 ± 0.47 vs. SR: 13.52 ± 0.47]
Narducci [19] WBC Preoperative:
WBC [AF: 7.24 ± 0.7 vs. SR: 8.27 ± 1.03]
Postoperative:
WBC [AF: 10.79 ± 1.58 vs. SR: 12.51 ± 1.43]
Limite [20] WBC Preoperative:
WBC [AF: 6.5 ± 0.36 vs. SR: 6.4 ± 0.4]
Postoperative:
WBC [AF: 12.07 ± 0.88 vs. SR: 10.72 ± 0.75]
Erdem [21] PC, MPV, WBC, NLR, RDW, MCV, Hb Preoperative:
PC [AF: 252.6 ± 61.5 vs. SR: 265.1 ± 59]
MPV [AF: 8.9 ± 1.4 vs. SR: 7.9 ± 1.2]
WBC [AF: 7.5 ± 4.3 vs. SR: 7 ± 3.5]
NLR [AF: 3.2 ± 1.9 vs. SR: 2.6 ± 1.2]
RDW [AF: 17 ± 0.3 vs. SR: 16.9 ± 0.4]
MCV [AF: 80.9 ± 8.3 vs. SR: 79.8 ± 8.8]
Hb [AF: 12.5 ± 1.8 vs. SR: 13 ± 1.5]
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First author Markers Levels
Ertas [22] MPV, WBC, RDW, Hb Preoperative:
MPV [AF: 9.2 ± 1.4 vs. SR: 9.5 ± 1.9]
WBC [AF: 8.9 ± 4.6 vs. SR: 8.5 ± 2.5]
RDW [AF: 13.9 ± 1.4 vs. SR: 13.3 ± 1.2]
Hb [AF: 15.4 ± 8.1 vs. SR: 14.1 ± 6.6]
Durukan [23] WBC, NLR Preoperative:
WBC [AF: 8.14 ± 2.11 vs. SR: 8.39 ± 2.36]
NLR [AF: 3.02 ± 2.3 vs. SR: 2.9 ± 2.1]
Postoperative:
WBC [AF: 15.11 ± 4.08 vs. SR: 15.16 ± 4.22]
NLR [AF: 9.34 ± 6.73 vs. SR: 10.07 ± 21.97]
Sabol [24] WBC Preoperative:
WBC [AF: 13.6 ± 3.6 vs. SR: 11.3 ± 3.6]
Postoperative:
WBC [AF: 13.7 ± 4.1 vs. SR: 11.4 ± 13.7]
Garcia [25] WBC Preoperative:
WBC [AF: 6.9 ± 1.7 vs. SR: 7.4 ± 1.8]
Gungor [26] WBC, HCT, Hb Preoperative:
WBC [AF: 8.54 ± 3.8 vs. SR: 7.66 ± 2.03]
HCT [AF: 40.2 ± 6.3 vs. SR: 41.2 ± 3.6]
Hb [AF: 13.4 ± 2.2 vs. SR: 13.7 ± 1.5]
Kaireviciute [27] PC, WBC, Hb Preoperative:
PC [AF: 236.7 ± 57.8 vs. SR: 236.2 ± 58.8]
WBC [AF: 7.3 ± 1.6 vs. SR: 6.8 ± 1.6]
Hb [AF: 14.02 ± 1.49 vs. SR: 14.4 ± 1.3]
Gibson [28] WBC, NLR, Hb Preoperative:
WBC [AF: 7.95 ± 0.4 vs. SR: 7.75 ± 0.4]
NLR [AF: 3.03 ± 0.25 vs. SR: 2.5 ± 0.21]
Hb [AF: 14.52 ± 0.31 vs. SR: 14.32 ± 0.25]
Postoperative:
WBC [AF: 13.72 ± 0.88 vs. SR: 12.17 ± 0.71]
NLR [AF: 9.19 ± 0.95 vs. SR: 7.4 ± 0.75]
Hb [AF: 10 ± 0.3 vs. SR: 9.95 ± 0.3]
Sood [29] WBC Postoperative:
WBC [AF: 12.25 ± 4.7 vs. SR: 10.91 ± 3.55]
Choi [30] WBC, HCT Preoperative:
WBC [AF: 7.1 ± 2.1 vs. SR: 7.3 ± 2]
HCT [AF: 39.3 ± 5.7 vs. SR: 39 ± 4.8]
Postoperative:
WBC [AF: 12.2 ± 4.3 vs. SR: 11.1 ± 3.2]
HCT [AF: 26.1 ± 3.3 vs. SR: 26.7 ± 3.3]
Fontes [31] WBC Preoperative:
WBC [AF: 9.2 ± 3.6 vs. SR: 6.8 ± 1.8]
Postoperative:
WBC [AF: 12.9 ± 3.4 vs. SR: 11.7 ± 3.4]
Lamm [32] WBC, Hb Preoperative:
WBC [AF: 6.8 ± 1.9 vs. SR: 6.8 ± 2.2]
Hb [AF: 13.4 ± 1.6 vs. SR: 13.7 ± 1.2]
Postoperative:
WBC [AF: 16.3 ± 6.5 vs. SR: 15 ± 4.2]
Abdelhadi [33] PC, WBC, Hb Preoperative:
PC [AF: 215 ± 62 vs. SR: 229 ± 59]
WBC [AF: 7.58 ± 2.2 vs. SR: 7.01 ± 1.83]
Hb [AF: 13.74 ± 1.72 vs. SR: 13.65 ± 1.81]
Postoperative:
WBC [AF: 13.7 ± 5.6 vs. SR: 9.8 ± 3.1]
AF — atrial fibrillation; Hb — haemoglobin; HCT — haematocrit; MCV — mean corpuscular volume; MPV — mean platelet volume; NLR — 
neutrophil-to-lymphocyte ratio; PC — platelet count; RBC — red blood cell; RDW — red blood cell distribution width; SR — sinus rhythm;  
WBC — white blood cell
Table 2 (cont). Information about haematological indices and these levels in each study
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of 0.53 FL (95% CI 0.45 to 0.60; p < 0.001, Fig. 2) with 
considerable heterogeneity among the studies (I2 = 91.7%; 
heterogeneity p < 0.001). 
WBC 
A total of 4460 cases were included from 20 studies, of whom 
1369 were recruited in the POAF group and 3091 in the POSR 
group (Table 1). The populations of the studies ranged from 
38 to 662 patients, 72.62% males (mean age, 64.86 years) 
(Table 1). Mean WBC count was 7.97 × 109/L in cases with 
the occurrence of POAF and 7.66 × 109/L in POSR (Table 2). 
Pooled analysis reported that the count of WBCs was higher 
in the POAF group (positive predictor) compared to the POSR 
group with WMD of 0.130 × 109/L (95% CI 0.08 to 0.18; 
p < 0.001) (Fig. 3). Significant heterogeneity was observed 
among the studies (I2 = 57.2%; heterogeneity p = 0.001).
NLR 
A total of 1726 patients were included from five studies, of 
them 549 were enrolled in the POAF group and 1177 in 
the POSR group (Table 1). The populations of the studies 
ranged from 106 to 657 patients, 79.56% males (mean age: 
65.05 years) (Table 1). Mean NLR was 2.97 in the POAF and 
2.51 in the POSR group (Table 2). Using a random effect 
model, pooled analysis indicated that the NLR was significantly 
higher in patients with POAF (positive predictor) compared to 
POSR with WMD of 0.33 (95% CI 0.30 to 0.37; p < 0.001, 
Fig. 4), with considerable heterogeneity among the studies 
(I2 = 94.2%; heterogeneity p < 0.001).
RDW 
A total of 500 patients were selected from four studies, of 
which 146 were allocated to the POAF group and 354 to 
the POSR group (Table 1). The populations of the studies 
ranged from 94 to 165 patients, 76.21% males (mean age, 
63.88 years) (Table 1). Mean of RDW was 15.03% in the POAF 
group and 14.62% in the POSR group (Table 2). Pooled analy-
sis showed that RDW was significantly higher in the POAF 
group (positive predictor) than in the POSR group with WMD 
of 0.36% (95% CI 0.26 to 0.45; p < 0.001, Fig. 5). There was 
remarkable heterogeneity between the studies (I2 = 95.3%; 
heterogeneity p < 0.001).
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Figure 1. Forest plot of weighted mean difference (WMD) for association between preoperative platelet count and occurrence of 
postoperative atrial fibrillation; CI — confidence interval; Pub — publication
Figure 2. Forest plot of weighted mean difference (WMD) for association between level of preoperative mean platelet volume 
and occurrence of postoperative atrial fibrillation; CI — confidence interval; Pub — publication
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Figure 3. Forest plot of weighted mean difference (WMD) for association between preoperative white blood cell count and 
occurrence of postoperative atrial fibrillation; CI — confidence interval; Pub: publication
Figure 4. Forest plot of weighted mean difference (WMD) for association between preoperative neutrophil-to-lymphocyte ratio 
and occurrence of postoperative atrial fibrillation; CI — confidence interval; Pub — publication
Figure 5. Forest plot of weighted mean difference (WMD) for association between preoperative red blood cell distribution width 
and occurrence of postoperative atrial fibrillation; CI — confidence interval; Pub — publication
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Preoperative secondary haematological indices 
Regarding pooled assessment analysis, both groups were simi-
lar regarding the level of HCT (number of studies = 4, WMD 
of –0.015 FL, 95% CI –0.40 to 0.37; p = 0.94 and I2 = 0.0%; 
heterogeneity p = 0.8) and Hb (number of studies = 12, 
WMD of 0.024 g/dL, 95% CI –0.033 to 0.08; p = 0.4 and 
I2 = 87.1%; heterogeneity p < 0.001). 
Association of postoperative haematological 
indices with the occurrence of POAF 
Mean WBC count was 13.29 × 109/L in the POAF group 
and 12.17 × 109/L in the POSR group (Table 2). Postop-
erative mean WBC count (number of studies = 11, WMD 
of 1.36 × 109/L, 95% CI 1.24 to 1.48; p < 0.001; Fig. 6; 
I2 = 83.6%; heterogeneity p < 0.001) and the level of NLR 
(number of studies = 2, WMD of 0.74, 95% CI 0.56 to 0.92; 
p < 0.001 and I2 = 99.2%; heterogeneity p < 0.001) were 
considerably higher in patients with POAF (positive predictors) 
compared to POSR cases.
Postoperative secondary haematological indices 
HCT and Hb levels were examined in at least two studies in-
cluded in the meta-analysis. The level of HCT (number of stud-
ies = 2, WMD of –0.43, 95% CI –0.81 to 0.05; p = 0.02 and 
I2 = 0.0%; heterogeneity p = 0.69) was lower in the POAF 
group (negative predictor) compared to the POSR group. The 
level of Hb (number of studies = 2, WMD of 0.023 g/dL, 95% 
CI –0.04 to 0.08; p = 0.49 and I2 = 65.7%; heterogeneity 
p = 0.08) was similar in both groups. 
Other parameters 
Regarding the association of the occurrence of POAF with 
preoperative haematological indices such as PDW, RBC count, 
MCV, and postoperative haematological parameters such as 
platelet count, PDW, MPV, RBC count, RDW, and MCV, the 
number of studies were insufficient for analysis.
Publication bias and subgroup analysis 
Begg’s tests revealed that all results were without publication 
bias except for the relationship between preoperative Hb levels 
and the occurrence of POAF (Supplemental Figures 1–11 
— see journal website). Classification according to probable 
heterogeneity agents and subgroup analyses are reported in 
detail in Supplemental Tables 2 and 3, respectively, see 
journal website.
DISCUSSION
Atrial fibrillation is a hazardous and widespread complication 
following CABG, with an incidence rate of 20% to 50% in 
patients undergoing CABG, with incidence peaks two to three 
days after surgery [34–36]. Administration of antiarrhythmic 
agents for prevention or treatment of AF can reduce its inci-
dence and recurrence rate. Nevertheless, the use of these drugs 
is not free of complications. Several surgical approaches during 
cardiothoracic surgeries such as posterior pericardiotomy are 
considered simple surgical methods that reduce the risk of post-
operative AF [34–36]. Reports have suggested that performing 
CABG and valve surgery at the same time using cardiopulmo-
nary bypass particularly with prolonged duration of surgery 
could significantly increase the incidence of POAF [35, 36]. 
POAF can precipitate postoperative morbidity and mortality, 
thus it is critical to initiate prophylactic measures based on risk 
stratification for the patients prone to POAF before its occur-
rence [4, 5]. An appropriate diagnostic modality should, on the 
one hand, facilitate preventive and therapeutic measures by 
timely diagnosis, and on the other hand, should not burden 
patients with exorbitant healthcare costs and be applicable in 
the majority of health centres throughout the world [9]. 
While using patient’s history, such as the history of cardiac 
arrhythmia, clinical workups, electrocardiogram, and Holter 
monitoring, can help in terms of diagnosis and control of AF, 
it should be noted that in clinical practice some diagnostic 
modalities routinely performed in all in-patients might be of 
Anatolevna 2016 0.10 (–1.55, 1.75) 0.51
Narducci 2014 –1.72 (–2.73, –0.71) 1.39
Limite 2014 1.35 (1.19, 1.51) 55.72
Durukan 2013 –0.05 (–0.98, 0.88) 1.63
Sabol 2012 2.30 (–4.79, 9.39) 0.03
Gibson 2010 1.55 (1.35, 1.75) 35.66
Sood 2009 1.34 (0.55, 2.13) 2.27
Choi 2009 1.10 (–0.01, 2.21) 1.14
Fontes 2009 1.20 (–0.71, 3.11) 0.38
Lamm 2006 1.30 (–0.14, 2.74) 0.67
Abdelhadi 2004 3.90 (2.38, 5.42) 0.61
Overall (I2 = 83.8%, p = 0.000) 1.36 (1.24, 1.48) 100.00
First author % WeightWMD (95% Cl)Year of Pub
0–9.39 9.39
Figure 6. Forest plot of weighted mean difference (WMD) for association between postoperative white blood cell count and 
recurrence of postoperative atrial fibrillation; CI — confidence interval; Pub — publication
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more clinical value than previously thought [4–6]. CBC test is 
one of the most common tests performed in patients hospi-
talised in cardiac care unit, ICU, and cardiac surgery wards, 
with multiple examinations before and after surgery [5–8]. It 
was recently reported that haematological parameters in CBC 
test, as well as coagulation and endothelial markers, may be 
reliable predictors of paroxysmal, persistent, and permanent 
AF in patients receiving pharmacotherapy, cardioversion, and 
catheter ablation [9]. Varasteh-Ravan et al. [8] reported that 
haematological indices in patients with ST-segment elevation 
myocardial infarction, who received streptokinase therapy, 
may predict clinical outcomes after treatment. Therefore, 
since CBC is sensitive to haemodynamic conditions, it can 
have a significant predictive power.
In the present study, we attempted to investigate the 
association of haematological indices in CBC test with the 
occurrence of AF in patients undergoing cardiac surgery. Our 
findings indicated that preoperative platelet count in patients 
with POAF was significantly lower than POSR patients; 
therefore, we reject the popular belief among physicians that 
patients with thrombocytosis are at higher risk of AF. Our previ-
ous findings showed an inverse relationship between platelet 
count and the risk of the occurrence of AF in patients with 
a history of paroxysmal, persistent, or permanent AF [9]. As 
a result, a decrease in platelet count might be associated with 
AF in patients undergoing cardiac surgery or those receiving 
pharmacotherapy or undergoing catheter ablation. A subgroup 
analysis also indicated an inverse relationship between platelet 
count and POAF in patients undergoing isolated CABG, while 
this relationship was not found in patients undergoing simulta-
neous CABG and valve surgery. Differences in type of surgery, 
comorbidities, such as diabetes and arterial hypertension, and 
the use of statins are proposed as factors of heterogeneity. 
Mean platelet volume is an important biomarker of platelet 
function. Many significant mediators of blood coagulation, 
inflammation, thrombosis, and atherosclerosis are secreted by 
large platelets [37]. MPV is also closely associated with coronary 
artery disease [37]. Patients with coronary artery disease and 
slow coronary blood flow were shown to have higher MPV com-
pared to the control group [38, 39]. The current study demon-
strated that MPV was considerably greater in patients with POAF 
compared to the control group, thus being a potential predictive 
marker for POAF. A subgroup analysis revealed diabetes and 
arterial hypertension as the factors of heterogeneity. Platelet 
characteristics were strongly associated with cardiovascular risk 
factors of hypertension and diabetes mellitus [9]. Weymann et 
al. [4] suggested that MPV, as a valuable haematological pa-
rameter in CBC test, could strongly predict the occurrence of 
paroxysmal, persistent, or permanent AF; therefore, MPV was 
confirmed to be added to the risk stratification of AF [4]. In the 
present study, we also emphasise that MPV not only predicts 
AF in patients receiving antiarrhythmic therapy or undergoing 
catheter ablation, but also firmly predicts the occurrence of 
POAF. Therefore, we recommend adding this haematological 
index to diagnostic criteria of AF.
Atrial fibrillation is associated with the infiltration of im-
mune cells and proteins mediating the inflammatory response 
in cardiac tissue [40]. Moreover, inflammation in the heart 
or systemic circulation can predict the occurrence of AF and 
recurrence in the general population and in patients after 
cardiac surgery, cardioversion, and catheter ablation [40]. 
Investigators have claimed that anti-inflammatory drugs played 
a considerable role in prevention of POAF by regulating in-
flammatory mediators; by inhibition of one of the mechanisms 
of AF, they not only reduced postoperative arrhythmia, but 
also strongly decreased consequent complications of AF [41]. 
They believed that inflammation and oxidative stress were the 
most important mechanisms of AF [41].
Our findings indicated that pre- and postoperative WBC 
were directly related to the occurrence of POAF because WBC 
count was significantly higher in patients with POAF compared 
to those with sinus rhythm. A subgroup analysis found diabetes 
and arterial hypertension, statin and angiotensin converting 
enzyme inhibitor therapy, cross-clamp time, and cardiopulmo-
nary bypass time as the factors of heterogeneity. Our previous 
findings indicate that WBC count was remarkably higher in 
patients with a history of AF undergoing cardioversion and 
catheter ablation, who developed recurrent AF, as compared 
to patients who had successful treatment, thus confirming the 
association of WBC count with the recurrence of AF [9]. Our 
new findings showed that regular WBC check before and after 
surgery may be of major importance in terms of detecting the 
inflammatory state and onset of infection, as well as making 
timely diagnosis of cardiovascular events, such as arrhythmias, 
within a short period of time. NLR is another haematological 
marker related to the inflammation-based pathogenesis of AF 
[42]. We confirm that the NLR level before and after surgery 
has a significant association with the occurrence of POAF. 
Summarising, WBC count and NLR may have a potential 
predictive power, particularly when used together.
Red blood cell distribution width is known as a param-
eter measuring variability in circulatory red cell size obtained 
in CBC tests [43]. Higher RDW represents the presence of 
anisocytosis, which is related to impaired erythropoiesis and 
RBC degradation and appears as chronic inflammation and 
increased oxidative stress [43]. In the present study, we found 
that the preoperative RDW level was considerably higher 
in patients with POAF as compared with the control group, 
confirming the fact that increased RDW in CBC test before 
surgery warns of the risk of AF. Several reports have recently 
emphasised the predictive role of RDW for clinical outcomes 
and haemodynamic status in patients suffering from heart 
failure, myocardial infarction, and acute coronary syndrome 
[44, 45], whereas no reports have been published regarding 
the difference in postoperative RDW between POAF and 
POSR groups. We recently pointed out that RDW has a re-
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markable predictive power for the occurrence and recurrence 
of paroxysmal, persistent, or permanent AF [9].
Anaemia is considered an independent predictor for 
morbidity and mortality in a number of cardiovascular dis-
eases, such as heart failure and myocardial infarction [46]. 
Sharma et al. [46] defined anaemia as an important predictor 
for hospitalisation and mortality in elderly patients with AF. It 
should be noted that anaemia caused by peri- and postopera-
tive bleeding, along with blood transfusion as a therapeutic 
strategy, can lead to an increased risk of AF by changing 
physiological set points and reduced proinflammatory state 
[46]. Alameddine et al. [47] reported that an increase in 
blood transfusion requirements was notably associated with 
an increased risk of the incidence of POAF. Our findings 
showed that there was no  difference in the levels of Hb and 
HCT before surgery and also Hb level after surgery between 
POAF and POSR groups. It is noteworthy that the level of 
these haematological indices was not significantly different 
between the two groups, probably due to homogeneity of 
patients enrolled in the studies, the small number of studies, 
the elective nature of surgical procedures performed, and 
the lack of significant bleeding events in the included stud-
ies. Considering these findings, we cannot accept or reject 
the present hypotheses about the association of anaemia with 
the occurrence of atrial fibrillation. 
Limitations of the study
This meta-analysis has several limitations. It is a study-level 
meta-analysis with an inherent lack of available data on 
end-points assessed in studies included in the meta-analy-
sis. Also, there are different definitions of arrhythmia and sinus 
rhythm between studies, and there is no data on various types 
of cardiothoracic surgeries. 
CONCLUSIONS
Haematological indices may predict the risk of POAF before 
surgery. These readily performed tests should definitely be 
taken into account in patients undergoing isolated CABG, 
valvular surgery, or combined procedures.
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